Additionally, FOXD2-AS1 exhibits aberrant expression in various malignancies and promotes HCC invasion and migration by sponging miR-206 and regulating MAP3K1 expression [61, 62]. This evidence concerns the gene FOXD2 and hepatocellular carcinoma.